Phase 2 trials investigate sitagliptin and methimazole as adjuvant therapies
Cleveland Clinic researchers pursue answers on basic science and clinical fronts
Findings implicate hydrogen sulfide dysfunction, point to potential treatment strategies
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement